Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine
NCT05547815 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 149
Last updated 2022-09-21
Summary
Evaluation of immune persistence after rabies vaccination in 150 people.
Conditions
- Rabies
- Antibody
Interventions
- BIOLOGICAL
-
5 doses program
Inoculate 5 doses of rabies vaccine, and collect blood at fixed time points to detect neutralizing antibody
Sponsors & Collaborators
-
Changchun Zhuoyi Biological Co., Ltd
lead OTHER
Principal Investigators
-
Li Miao, Dr · Changchun Zhuoyi Biological Co., Ltd
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 10 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-11
- Primary Completion
- 2020-12-17
- Completion
- 2021-11-08
Countries
- China
Study Locations
More Related Trials
-
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)
NCT05969626 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
NCT06078423 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
NCT07055295 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children
NCT02991872 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
NCT07021703 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)
NCT07338786 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
NCT07055893 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen
NCT01067079 ·Status: TERMINATED
-
To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)
NCT06177249 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
NCT07275645 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years
NCT06132789 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans
NCT02288286 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
NCT07055880 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans
NCT02281396 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
NCT05832073 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Purified Rabies Vaccine for Human Use (Chick-embryo Cell)
NCT00345319 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
NCT02177032 ·Status: COMPLETED ·Phase: PHASE3
-
Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
NCT06548139 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
NCT07120464 ·Status: RECRUITING
-
Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
NCT01173302 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunity Duration of Rabies Vaccine and Booster Dose Effects at 10 Years Post-primary Vaccination
NCT03774628 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia
NCT05684185 ·Status: COMPLETED
-
A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children
NCT03192371 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
NCT05937113 ·Status: COMPLETED ·Phase: PHASE4
-
Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year
NCT03700242 ·Status: COMPLETED ·Phase: PHASE3